*It may take up to 4 to 6 weeks for maximum clinical response.
†Reduction of veterinary clinical ear scores in a masked randomised multicentre field trial in client-owned dogs with otitis externa in Germany, France and the Netherlands. Ear scores based on the OTIS-3 scale, an established clinical scoring system used in dogs with otitis externa to assess erythema, oedema, erosion and the presence of exudate. Each sign is evaluated on a scale of 0 (absent) to 3 (severe) and the OTIS-3 score calculated (maximum score of 12). In many trials evaluating otitis externa in dogs, an OTIS-3 score of 5 or more is required for inclusion. Each ear is assessed and scored at each visit, enabling the response to treatment to be assessed objectively. An OTIS-3 score of 5 or more is required for inclusion. Each ear is assessed and scored at each visit, enabling the response to treatment to be assessed objectively. An OTIS-3 score of 3 or less is considered a healthy ear.
Reference: 1. European Medicines Agency. Mometamax Ultra: EPAR – Product Information & Public Assessment Report. 2022.
ROI: POM NI:POM-V
For further information about side effects,
precautions, warnings and contra-indications please consult the product SPC,
packaging leaflets or MSD Animal Health, Red Oak North, South County Business
Park, Leopardstown, Dublin 18, Ireland.
Tel: +353 (0) 12970220 Email: email@example.com
USE MEDICINES RESPONSIBLY